3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Paclitaxel
16
Carboplatin
14
Cisplatin
12
Oxaliplatin
9
Hyperthermic Intraperitoneal Chemotherapy
9
Cytoreduction Surgical Procedures
9
Fluorouracil
7
Bevacizumab
7
Doxorubicin
5
Leucovorin
4
Gemcitabine
4
catumaxomab
3
Docetaxel
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
nintedanib
2
liposomal doxorubicin
2
epothilone B
2
Surgical Procedures, Operative
2
Palliative Care
2
Mitomycin
2
Laparoscopy
2
Interviews as Topic
2
Drug Therapy
2
Blood Specimen Collection
2
veliparib
1
tremelimumab
1
talimogene laherparepvec
1
strattice
1
sodium thiosulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Peritoneal Neoplasms
×
genexol-PM
×
Clear all
NCT03618758
2023-12-05
IPLUS
Seoul National University Bundang Hospital
Phase 1/2
Completed
35 enrolled